EC Number |
BRENDA No. |
Title |
Journal |
Volume |
Pages |
Year |
Organism |
PubMed ID |
---|
3.4.23.B24 | 754637 |
A novel strategy to improve protein secretion via overexpression of the SppA signal peptide peptidase in Bacillus licheniformis |
Microb. Cell Fact. |
16 |
70 |
2017 |
Bacillus licheniformis |
28438200 |
3.4.23.B24 | 754637 |
A novel strategy to improve protein secretion via overexpression of the SppA signal peptide peptidase in Bacillus licheniformis |
Microb. Cell Fact. |
16 |
70 |
2017 |
Bacillus licheniformis BL10 |
28438200 |
3.4.23.B24 | 755255 |
Bunyamwera orthobunyavirus glycoprotein precursor is processed by cellular signal peptidase and signal peptide peptidase |
Proc. Natl. Acad. Sci. USA |
113 |
8825-8830 |
2016 |
Homo sapiens |
27439867 |
3.4.23.B24 | 755089 |
Differential inhibition of signal peptide peptidase family members by established gamma-secretase inhibitors |
PLoS ONE |
10 |
e0128619 |
2015 |
Homo sapiens |
26046535 |
3.4.23.B24 | 755089 |
Differential inhibition of signal peptide peptidase family members by established gamma-secretase inhibitors |
PLoS ONE |
10 |
e0128619 |
2015 |
Mus musculus |
26046535 |
3.4.23.B24 | 755089 |
Differential inhibition of signal peptide peptidase family members by established gamma-secretase inhibitors |
PLoS ONE |
10 |
e0128619 |
2015 |
Plasmodium sp. |
26046535 |
3.4.23.B24 | 754400 |
Discovery of the first potent, selective, and orally bioavailable signal peptide peptidase-like 2a (SPPL2a) inhibitor displaying pronounced immunomodulatory effects in vivo |
J. Med. Chem. |
61 |
865-880 |
2018 |
Rattus norvegicus |
29359565 |
3.4.23.B24 | 754400 |
Discovery of the first potent, selective, and orally bioavailable signal peptide peptidase-like 2a (SPPL2a) inhibitor displaying pronounced immunomodulatory effects in vivo |
J. Med. Chem. |
61 |
865-880 |
2018 |
Homo sapiens |
29359565 |
3.4.23.B24 | 754400 |
Discovery of the first potent, selective, and orally bioavailable signal peptide peptidase-like 2a (SPPL2a) inhibitor displaying pronounced immunomodulatory effects in vivo |
J. Med. Chem. |
61 |
865-880 |
2018 |
Mus musculus |
29359565 |
3.4.23.B24 | 755184 |
Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins |
PLoS ONE |
14 |
e0214968 |
2019 |
Homo sapiens |
30973897 |